Department of Otolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang, 330006, Jiangxi Province, China.
Jiangxi Biomedical Engineering Research Center for Auditory Research, Nanchang, 330006, China.
Eur Arch Otorhinolaryngol. 2021 May;278(5):1355-1364. doi: 10.1007/s00405-020-06191-5. Epub 2020 Jul 11.
To investigate optimal approaches for appropriate removal of the parotid gland in the management of squamous cell carcinoma (SCC) of the external auditory canal (EAC) at different tumor stages.
In total, 39 patients with SCC of EAC treated at the Second Affiliated Hospital of Nanchang University between September 2003 and April 2019 were enrolled in this study. All patients underwent lateral temporal bone resection or subtotal temporal bone resection. Total parotidectomy was performed in patients with direct parotid invasion. Superficial parotidectomy was performed in patients with parotid node metastasis and patients with advanced stages without evidence of parotid involvement.
The mean follow-up period was 68.7 months. Local recurrences or distant metastases occurred in five patients (12.8%). The 5-year overall survival rate was 78.4%. The 5-year survival rate was 100% in early stage (T and T) patients, and 58.9 and 50.0% in patients staged III and IV, respectively. Direct parotid invasion was observed in only advanced-stage patients, while parotid node metastasis was noted in both early and advanced-stage patients preoperatively. There were no significant differences (χ = 0.1026; p = 0.749) between different tumor primary locations. However, soft tissue or preauricular organs became vulnerable once the anterior wall was infiltrated or eroded.
Parotid management is important for achieving safer and wider tumor-free margins. Total parotidectomy should be mandatory for all advanced-staged (T and T) patients. An optimal decision for parotid management in early stages depends on the infiltration or erosion of the anterior wall of the EAC.
探讨不同肿瘤分期外耳道鳞状细胞癌(SCC)治疗中腮腺恰当切除的最佳方法。
回顾性分析 2003 年 9 月至 2019 年 4 月南昌大学第二附属医院收治的 39 例外耳道 SCC 患者的临床资料,所有患者均行颞骨外侧切除术或次全颞骨切除术。对于直接侵犯腮腺的患者行腮腺全切除术,对于有腮腺淋巴结转移和无腮腺受累证据的晚期患者行腮腺浅叶切除术。
平均随访时间为 68.7 个月。5 例(12.8%)患者出现局部复发或远处转移。5 年总生存率为 78.4%。早期(T 和 T)患者的 5 年生存率为 100%,Ⅲ期和Ⅳ期患者的 5 年生存率分别为 58.9%和 50.0%。仅晚期患者有直接腮腺侵犯,而术前早期和晚期患者均有腮腺淋巴结转移。不同肿瘤原发部位之间无显著差异(χ = 0.1026;p = 0.749)。然而,一旦前壁被浸润或侵蚀,软组织或耳前器官就会变得脆弱。
腮腺的处理对于获得更安全、更广泛的无肿瘤切缘至关重要。所有晚期(T 和 T)患者均应行腮腺全切除术。早期腮腺处理的最佳决策取决于外耳道前壁的浸润或侵蚀。